News
The company LUMIER PHARMA LLC has contributed to the realization of the charitable action “I will survive!”11 October 2012September 12, 2012, a charity concert “I will survive!” was held in Kiev, the initiator of which was the “Association for the disabled and patients with chronic lymphoproliferative disorders” and the rock band DRUGA Rika. |
Receiving of a GMP certificate – strategically important event for the company LUMIER PHARMA LLC11 September 2012August 27, 2012 the State Service of Ukraine for Medicinal Products issued a certificate of GMP compliance to LUMIER PHARMA LLC. |
Themutual meeting of LUMIER PHARMA LLC and F.Hoffmann-La Roche Ltd with the representatives of the All-Communities Advisory Council on Access to Treatment in Ukraine (UCAB )14 March 2012On March 14, 2012, the mutual meeting with the representatives of the All-Communities Advisory Council on Access to Treatment in Ukraine was held. The main objective of the meeting was to introduce to the meeting participants the medicine PEGFERON, PEG-interferon alpha 2, manufactured by LUMIER PHARMA LLC and the F.Hoffmann-La Roche Ltd Company. |
Next stage of cooperation between LUMIER PHARMA LLC and F.Hoffmann-La Roche Ltd7 February 2012At the beginning of 2012, LUMIER PHARMA LLC registered two medications developed by the F.Hoffmann-La Roche Ltd Company that will be produced in Ukraine in the framework of a mutual project with LUMIER PHARMA LLC. |
Oktapharma specialists performed the audit of the LUMIER PHARMA LLC28 July 2011In June 2011, the specialists of the world’s leading manufacturer of high-quality plasma medicines, the Octapharma Company, performed external audit of the LUMIER PHARMA LLC. |
F.Hoffmann-La Roche Ltd performed the inspection of LUMIER PHARMA LLC production capacity and internal processes25 March 2011The world’s leading manufacturer of pharmaceuticals, the F.Hoffmann-La Roche Ltd Company, conducted an examination and inspection of LUMIER PHARMA LLC production capacity and internal processes to verify the successful fulfillment of the final stage of biotechnological medicines production in Ukraine. |
LUMIER PHARMA LLC and F.Hoffmann-La Roche Ltd social project on the production of PEGFERON, PEG-interferon alpha-2a in Ukraine15 February 2010Commenced in March, 2010 was the first stage of work on the mutual social project of the world’s leading manufacturer of pharmaceuticals, the F.Hoffmann-La Roche Ltd Company, and the domestic company LUMIER PHARMA LLC. |
| Pages: |  |
 |
1 | 2 | 3 | 4 |
© 2008 - 2012 Lumier Pharma. All rights reserved.
© 2012 made by mc design
mc design - Creative Design Lab
© 2012 made by mc design